Skip to content

U.S. News debuts 2026-2027 best GLP-1 telehealth platform ratings

Inaugural ratings evaluate leading online GLP-1 platforms to help consumers make informed decisions in the fast-growing weight management market.

Photo by Haberdoedas / Unsplash

WASHINGTON – U.S. News & World Report, a global leader in healthcare decision support, has unveiled its inaugural Best GLP-1 Telehealth Platforms ratings. The new rankings assess 20 online providers offering FDA-approved, brand-name GLP-1 medications, including Wegovy, Zepbound, Ozempic and Foundayo, helping consumers make informed choices in the growing digital weight management market.

Because prescription weight-loss treatment is not one-size-fits-all, U.S. News emphasizes the importance of working with a healthcare provider to determine whether a telehealth platform aligns with an individual's medical needs and treatment goals.

The release comes as GLP-1 medications continue to reshape the healthcare landscape. In a U.S. News survey published in January 2026 on Top Health Trends for 2026, 52% of health and nutrition experts indicated the expanded use of GLP-1s as the trend that would make the most significant impact on public health this year.

With demand for GLP-1’s surging, millions of Americans are turning to online telehealth platforms to access these medications. However, navigating complicated fee structures, varying levels of doctor oversight and complex insurance processes makes finding transparent and reliable options difficult. U.S. News’ new ratings cut through the noise by evaluating platforms on clinical rigor, pricing transparency, insurance concierge support and long-term care management.

“Finding transparent cost details and reliable decision support data is often confusing to consumers,” said Gretel Schueller, managing editor of health at U.S. News. “U.S. News’ GLP-1 telehealth platform ratings were created to bring clarity to a complex marketplace. By thoroughly evaluating platforms across six unique patient-focused pillars, we aim to help American consumers confidently choose a platform – in consultation with their doctor – that aligns with their budget and health goals.”

Top-Rated GLP-1 Telehealth Platforms

Out of 20 platforms evaluated, 11 achieved top ratings from U.S. News based on a comprehensive 5-point scale:

Top Performers by Category

U.S. News recognized individual standouts across four specific categories:

Category
Winner
Best for Insurance Support
Amazon One Medical
Best for Clinical Support
Found
Best for Supplemental Support
Noom
Best for Customer Satisfaction
Ro

Latest